2R

Azelis Group NVFRA Azelis Group Stock Report

Last reporting period 30 Jun, 2024

Updated 13 Nov, 2024

Last price

Market cap $B

5.25

Middle

Exchange

XFRA - Deutsche Boerse AG

2R7.F Stock Analysis

2R

Avoid

Based on Eyestock quantitative analysis, 2R7.F`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

40/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

9.8 %

Undervalued

Market cap $B

5.25

Dividend yield

1.26 %

Shares outstanding

233.85 B

Azelis Group NV is an investment holding company engaged in the provision of services relating to the specialty chemicals and food ingredients industry. The company is headquartered in Berchem, Antwerpen and currently employs 3,825 full-time employees. The company went IPO on 2021-09-17. Life science segment of this company includes food and health, personal care, specialty agrochemicals and horticulture, pharmaceuticals, homecare and industrial cleaning and animal nutrition. Industry Chemical segment of this company includes coatings adhesives, sealants and elastomers, and construction materials, rubber and plastic additives, lubricants and metal, working fluids and other end markets, such as: electronics, essential chemicals and textiles, leather and paper. The company also offers inventory management, regulatory and value-added formulation services such as packaging, filing, mixing and blending.

View Section: Eyestock Rating